HIVNCT07564193
The Coach Mpilo Study: Evaluation of a Peer-led Intervention to Promote Engagement in HIV Care for Men Living With HIV
A study testing Coach Mpilo in people with HIV, run by University of Cape Town at 1 site in South Africa.
Trial summary
Developed in South Africa using extensive input from community members and healthcare professionals, Coach Mpilo is a peer support intervention that was designed to improve health outcomes for men living with HIV. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- HIV
- What is being tested?
- Coach Mpilo
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 800 participants
- Where
- 1 siteSouth Africa
- Study dates
- 11 May 2026to Sep 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Male (cisgender or transgender);
- aged ≥18 years;
- previously receiving HIV care at the study clinic;
- missed their most recent ART (antiretroviral therapy) clinic appointment by >28 days;
- not planning to relocate to another region within the next 12 months;
- able and willing to provide informed consent;
- not currently taking ART
Who cannot join
- not meeting inclusion criteria
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Harsha Thirumurthy, PhD contact
South Africa1 site
Multisite study with several health care facilities
Durban, KwaZulu-Natal
Thabani Mhlonga, +27799790280, Thabani.Mhlongo@kznhealth.gov.za
About this study
Official title: The Coach Mpilo Study: Evaluation of a Peer-led Intervention to Promote Engagement in HIV Care for Men Living With HIV in South Africa
Developed in South Africa using extensive input from community members and healthcare professionals, Coach Mpilo is a peer support intervention that was designed to improve health outcomes for men living with HIV. Coach Mpilo engages men living with HIV as coaches who provide support to their peers and help them address psychosocial barriers in accessing and staying in HIV care. The peers employed by Coach Mpilo provide individualized assistance to men who are struggling with medication adherence and clinic visits, focusing on specific barriers ranging from knowledge about the benefits of HIV treatment, stigma, mental health, and social isolation.
Through a randomised control trial, this project will (1) determine the impact of the Coach Mpilo intervention on retention in HIV care, viral suppression, HIV treatment adherence, mental health, HIV stigma, and economic status; (2) identify populations of men who may not benefit from the intervention and require alternative support; and (3) assess the intervention's cost-effectiveness.
Read the detailed description
Study setting The study will be conducted in KwaZulu-Natal (KZN), the province in South Africa with the highest adult HIV prevalence: 16%-24% (model estimates), 22% (survey estimates). The study will be conducted in about 13 primary healthcare facilities based in the eThekwini District.
Aim 1: Determine the effects of Coach Mpilo on retention in care among men living with HIV In partnership with the Department of Health in KwaZulu-Natal Province, eThekwini Municipality, The Health Systems Trust (HST) and Matchboxology (a South African organisation that designs health and social programs) a randomised controlled trial (RCT) will be conducted with men living with HIV who have dropped out of HIV care (i.e., having missed a clinic appointment by >28 days).
Recruitment: Study staff will be trained by HST as Linkage Officers. As Linkage Officers, they will contact men who have missed clinic appointments via telephone, encourage return to care, and ask to meet privately at local venues. At the in-person meeting the Linkage Officers will invite eligible participants to enrol in the study.
Consenting process: Written informed consent will be obtained.
Data collection Baseline survey: Study staff will administer a baseline questionnaire to obtain information on, among other things, participants' demographic characteristics, socio-economic status, health behaviour, future outlook, internalized stigma and mental health.
Follow-up survey: Study staff will contact participants at six months and administer an in-person follow-up survey; many of the questions administered at baseline will be assessed again.
Clinic records: Participants' health outcome data will be obtained from electronic clinic data via TIER.Net (South Africa's national electronic HIV/TB monitoring system), to assess individual- and facility-level outcomes related to HIV. Where necessary physical clinic files will be reviewed for confirmation. In addition, participants' data on laboratory tests relevant for HIV care (including viral load tests) will be requested from the National Health Laboratory Services (NHLS).
Coach Log Book: To collect data on the engagement between coaches and their clients, the coaches will maintain a log book of the dates, duration and mode (e.g., in-person, telephone call, WhatsApp messages) of contact with clients.
Randomization: Following the baseline survey, participants will be randomized (1:1) to a control group that receives the SOC and an intervention group that receives SOC plus the Coach Mpilo intervention.
Analyses: Primary analysis will be intention-to-treat using a logistic regression model that includes clinic fixed effects and month of enrollment, and controls for baseline participant characteristics that are significantly different between study groups. Similar analyses will be conducted for each secondary outcome.
Sample size and power calculations: With a sample size of 786 participants and 50% retention in care at 12 months, the study has 80% power to detect a difference of 10 percentage points between study groups. As a result, the study will aim to recruit about 800 participants in the Aim 1 trial.
Aim 2: Identify the populations of men who are not reached by and do not respond to Coach Mpilo In the intervention group, intervention uptake and amount of engagement participants have with a coach will be measured. Primary quantitative analysis will assess the determinants of uptake within the intervention group to advance the limited evidence on sub-groups that are typically missed by peer-led interventions and therefore require different types of support. Qualitative interviews will also be conducted to better understand program uptake and engagement with a coach.
Participants: Aim 2 will be conducted with data collected from coaches and from Aim 1 trial participants.
Follow-up procedures and data collection: In-depth interviews (IDIs) with participants in the intervention arm who decline a coach. The study will conduct about 15 IDIs with 1) men who decline the support of a coach to understand reasons they did not engage with a coach; 2) about 15 IDIs with men who, after initial engagement, decline the support of a coach, this will be in order to understand reasons they chose to end engagements with a coach; 3) about 15 IDIs with participants who receive support from a coach to understand engagement with coaches and elicit insights on reasons why the intervention may have worked for some participants but not others. IDIs will be conducted at about 6 months, when engagement with a coach will have ended.
IDIs with all coaches (about N=7) involved in the study will be conducted to gain insights on their engagement with participants.
Analyses: Primary quantitative analysis: Among Aim 1 intervention group participants analysis will evaluate factors associated with declining the offer of a coach using logistic regression, controlling for potential covariates. Qualitative data analysis: Data analysis will be iterative, and include both deductive and inductive approaches to thematic analysis.
Aim 3: Assess the cost-effectiveness of the Coach Mpilo program To inform strategic policy decisions about the scale-up of Coach Mpilo, and how it compares in cost and cost-effectiveness against current standard of care treatment, as well as other HIV interventions, we will conduct an economic evaluation. Data collection includes: cost-related data and resource utilization data to construct cost estimates for both arms. These data will be combined with retention in care data from Aim 1 to determine average costs per client retained in care and incremental cost per additional person retained. As part of the analysis, a sub-analysis will be conducted to adjust the cost estimates to reflect implementation in a routine care setting, excluding research-related expenses such as start-up and study-specific costs. This will provide more realistic national-level scale-up cost estimates for Coach Mpilo. Epidemiological modeling based on effectiveness estimates from Aim 1, will use the Thembisa model to estimate several long-term health outcomes, including life years saved and HIV infections averted due to onward transmission. These long-term health outcomes will form the basis to estimate the cost-effectiveness analysis of Coach Mpilo. To compare Coach Mpilo to other HIV prevention and treatment options in South Africa with the broader aim of informing strategic policy decisions, study estimates will be incorporated into the South Africa HIV Investment Case, a prominent initiative that assesses the relative cost-effectiveness of different HIV interventions and aims to inform government of the optimal mix of interventions that also accounts for allocative efficiency.
Analyses
The analyses will be conducted in three phases:
Cost analysis: a multiprong approach will be used that incorporates top-down and bottom-up costing methodologies to construct a cost for both standard of care and Coach Mpilo arms.
Cost-effectiveness analysis: both intermediate and long-term cost effectiveness analysis (using an HIV transmission model) will be conducted, comparing Coach Mpilo to standard of care.
Integration into the HIV Investment Case: the cost-effectiveness of Coach Mpilo to other HIV prevention and treatment options in South Africa will be compared to inform strategic policy decisions for the South African government.
Aim 4: Assess the acceptability, feasibility and fidelity of the Coach Mpilo program To inform intervention refinements and policy decisions on the scale-up of Coach Mpilo and peer-led interventions more generally, quantitative and qualitative assessment of implementation outcomes will be conducted alongside effectiveness and cost-effectiveness of the intervention. Implementation outcomes will be viewed as important for evaluation of complex health interventions in research and practice, providing indications into the implementation process as preconditions for attaining intended intervention engagement and health outcomes.
Sekhon's 2017 Theoretical Framework for Acceptability (TFA) will be used to assess the feasibility and acceptability of the intervention, informing interpretation of effectiveness overall (Aim 1), for sub-groups (Aim 2), and cost-effectiveness (Aim 3) by describing how acceptable the intervention is and how feasible the intervention is to deliver, from different stakeholder perspectives, and by describing the fidelity of the intervention.
The following data will be collected: i) primary quantitative survey data at baseline and six month follow-up (through Aim 1 survey instruments); ii) primary qualitative data from intervention arm participants that decline a coach, participants who are supported by a coach at six-month follow up, and coaches immediately after the intervention stops being implemented (through Aim 2 IDI instruments); iii) routine administrative data during intervention preparation and implementation.
Quantitative: At baseline, participants' affective attitude and values alignment will be assessed to understand prospective acceptability. In the follow up survey with intervention arm participants, the Acceptability of Intervention Measure (AIM)19, and the Client Satisfaction Questionnaire (CSQ-8) will be asked.
Qualitative: Follow-up in-depth-interviews described in Aim 2 include topics which answer our implementation research questions, focusing on retrospective acceptability
Coach log: an existing routine administrative data collection tool has been adapted to focus on implementation choices, their determinants, and coach-participant relationship quality.
Coach-to-Coach WhatsApp Group: the implementing partner routinely establishes a WhatsApp group used by Coaches and the Squad Manager (i.e. not including any clients/participants). Data from this group will include challenges Coaches are facing and solutions suggested by other coaches.
Monthly and quarterly implementation reports and follow-up discussions: these reports will be developed by Matchboxology, providing both quantitative data on reach and their own observations on fidelity, reach, mechanisms of change and implementation strategies and determinants.
Analysis: Quantitative analysis. Among Aim 1 intervention group participants, descriptive analysis of data from the AIM and CSQ-8 scales and linear regression analysis will be conducted to assess what factors at baseline were associated with these scales. Qualitative data analysis. Ongoing saturation analyses will be conducted, based on iterative coding during data collection. Data analysis will be iterative, and include both deductive and inductive approaches to thematic analysis.
- Conditions
- HIV
- Being tested
- Coach Mpilo
- Keywords
- HIV, antiretroviral therapy (ART), re-engagement in HIV care, linkage to care, peer-support, Coach Mpilo, men living with HIV, South Africa, ARV
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Coach MpiloBehavioural
The experimental group receives the standard of care for the control group (see control group description) and the Coach Mpilo intervention. Coach Mpilo employs 'coaches' (a term found to resonate with men and the concept of 'getting back in the game') to work 1-on-1 with men living with HIV ('players') and tailor support for each man to help him re-engage and stay in care. Coaches provide support for a period of up to six months, during which they engage with clients about once every week, with greater contact as needed based on the complexity of challenges faced. Coach Mpilo provides one-on-one, in-person support tailored to the individual needs of men living with HIV. As such, it may address the complex and varying psychosocial barriers to HIV care that traditional clinic-based interventions typically overlook. Coach Mpilo employs men living openly with HIV as coaches. This leverages the coaches' personal experiences to create a safe and supportive environment for clients.
| Study group | Role | What they receive |
|---|---|---|
| Control group | No intervention | Standard of care (SOC) in our study is a once-off telephonic contact by a Study Linkage Officer to encourage the participant to return to HIV care. The Linkage Officer is trained to conduct the call in line with the South African National Guidelines on tracing and recall which involved making telephonic contact with an individual who has missed their HIV clinic appointment by 7 days. The National Guidelines for tracing also include a potential home visit if the telephone call is unsuccessful. Given our study sample is limited to men who have missed HIV clinic appointments by more than 28 days, all participants should already have received the standard tracing services provided by the health facility. In the study we conduct the tracing telephone call again to make sure all participants have received this service. No other intervention is provided. |
| Coach Mpilo group | Experimental | The experimental group receives the standard of care for the control group (see control group description) and the Coach Mpilo intervention. Coach Mpilo employs 'coaches' (a term found to resonate with men and the concept of 'getting back in the game') to work 1-on-1 with men living with HIV ('players') and tailor support for each man to help him re-engage and stay in care. Coaches provide support for a period of up to six months, during which they engage with clients about once every week, with greater contact as needed based on the complexity of challenges faced. Coach Mpilo provides one-on-one, in-person support tailored to the individual needs of men living with HIV. As such, it may address the complex and varying psychosocial barriers to HIV care that traditional clinic-based interventions typically overlook. Coach Mpilo employs men living openly with HIV as coaches. This leverages the coaches' personal experiences to create a safe and supportive environment for clients. Receives: Behavioral: Coach Mpilo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Retention in HIV care
Indicates whether a participant attended a follow-up clinic visit on or before 12 months after study enrolment and obtained adequate supply of antiretroviral therapy (ART) medication to have medication available at 12 months
Measured: 12 months post study enrolment
Secondary outcomes (14)
ART clinic visit by 6 months
Indicates whether an participant attends an antiretroviral therapy (ART) related clinic visit within 6 months of study enrolment
Measured: 6 months post study enrolment
Retention in HIV care at 6 months
Indicates whether a participant attended a follow-up clinic visit on or before 6 months after study enrolment and obtained adequate supply of antiretroviral therapy (ART) medication to have medication available at 6 month
Measured: 6 months post study enrolment
Viral load test completed at 6 months
Indicates whether a participant completed an HIV viral load test within 6 months of study enrolment
Measured: 6 months post study enrolment
Viral suppression at 6 months
Indicates whether a participant had a viral load test conducted between 3-9 months after study enrolment and the test result was an HIV viral load <50 copies/ml
Measured: 3 to 9 months post study enrolment
Viral suppression at 12 months
Indicates whether a participant had a viral load test conducted between 9-15 months after study enrolment and the test result was an HIV viral load <50 copies/ml
Measured: 9 to 15 months post study enrolment
HIV status disclosure to sexual partners
Indicates whether a participant disclosed their HIV status to all sexual partners reported in the 6 months prior to the 6 month follow-up survey
Measured: 6 months post study enrolment
PHQ-9 scale
The participant's score on the PHQ-9 scale, which assessed symptoms of depression. The Patient Health Questionnaire-9 (PHQ-9) score ranges from 0 to 27, with higher scores indicating greater depression severity.
Measured: 6 months post study enrolment
Mild to severe symptoms of mental depression
Binary indicator of PHQ-9 score ≥5
Measured: 6 months post study enrolment
Moderate to severe symptoms of mental depression
Binary indicator of PHQ-9 score ≥10
Measured: 6 months post study enrolment
GAD-7 scale
The participant's score on the GAD-7 scale, which assesses symptoms of anxiety. The GAD-7 (Generalized Anxiety Disorder-7) scale ranges from 0 to 21, with higher scores indicating greater anxiety severity.
Measured: 6 months post study enrolment
Mild to severe symptoms of anxiety
Binary indicator of GAD-7 score ≥5
Measured: 6 months post study enrolment
Moderate to severe symptoms of anxiety
Binary indicator of GAD-7 score ≥10
Measured: 6 months post study enrolment
Internalised stigma
Participant's score on the internalised stigma scale. The score ranges from 0 to 15, with higher scores representing greater internalised stigma.
Measured: 6 months post study enrolment
Employment
Indicates whether a participant did any kind of work for pay or profit in the past 7 days
Measured: 6 months post study enrolment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 May 2026
- Study start11 May 2026 (estimated)
- Primary completionSep 2027 (estimated)
- Study completionSep 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HIVStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 800 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Cape Town
- Sponsor type
- University, hospital or other
- Collaborators
- University of Pennsylvania, University of Witwatersrand, South Africa
- Responsible party
- Principal investigator, Brendan Maughan-Brown, University of Cape Town
- Investigators
- Brendan G Maughan-Brown, PhD, Principal investigator, University of Cape TownHarsha Thirumurthy, PhD, Principal investigator, University of Pennsylvania
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07564193
- Sponsor's protocol ID
- UCT00040913
- Status last verified
- May 2026
- First submitted
- 26 Apr 2026
- Last updated
- 11 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Survey data and in-depth interview data; excluding personal identifying information
Study at a glance
From the registry record, last updated by the sponsor on 11 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Coach Mpilo Study: Evaluation of a Peer-led Intervention to Promote Engagement in HIV Care for Men Living With HIV in South Africa
- ClinicalTrials.gov ID
- NCT07564193
- Acronym / sponsor ID
- UCT00040913
- Conditions
- HIV
- Keywords
- HIV, antiretroviral therapy (ART), re-engagement in HIV care, linkage to care, peer-support, Coach Mpilo, men living with HIV, South Africa
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 800 participants (estimated)
- Lead sponsor
- University of Cape TownUniversity, hospital or other
- Collaborators
- University of Pennsylvania, University of Witwatersrand, South Africa
- Study start
- 11 May 2026 (estimated)
- Primary completion
- Sep 2027 (estimated)
- Study completion
- Sep 2027 (estimated)
- First posted
- 4 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Developed in South Africa using extensive input from community members and healthcare professionals, Coach Mpilo is a peer support intervention that was designed to improve health outcomes for men living with HIV. Coach Mpilo engages men living with HIV as coaches who provide support to their peers and help them address psychosocial barriers in accessing and staying in HIV care. The peers employed by Coach Mpilo provide individualized assistance to men who are struggling with medication adherence and clinic visits, focusing on specific barriers ranging from knowledge about the benefits of HIV treatment, stigma, mental health, and social isolation.
Through a randomised control trial, this project will (1) determine the impact of the Coach Mpilo intervention on retention in HIV care, viral suppression, HIV treatment adherence, mental health, HIV stigma, and economic status; (2) identify populations of men who may not benefit from the intervention and require alternative support; and (3) assess the intervention's cost-effectiveness.
Detailed description
Study setting The study will be conducted in KwaZulu-Natal (KZN), the province in South Africa with the highest adult HIV prevalence: 16%-24% (model estimates), 22% (survey estimates). The study will be conducted in about 13 primary healthcare facilities based in the eThekwini District.
Aim 1: Determine the effects of Coach Mpilo on retention in care among men living with HIV In partnership with the Department of Health in KwaZulu-Natal Province, eThekwini Municipality, The Health Systems Trust (HST) and Matchboxology (a South African organisation that designs health and social programs) a randomised controlled trial (RCT) will be conducted with men living with HIV who have dropped out of HIV care (i.e., having missed a clinic appointment by >28 days).
Recruitment: Study staff will be trained by HST as Linkage Officers. As Linkage Officers, they will contact men who have missed clinic appointments via telephone, encourage return to care, and ask to meet privately at local venues. At the in-person meeting the Linkage Officers will invite eligible participants to enrol in the study.
Consenting process: Written informed consent will be obtained.
Data collection Baseline survey: Study staff will administer a baseline questionnaire to obtain information on, among other things, participants' demographic characteristics, socio-economic status, health behaviour, future outlook, internalized stigma and mental health.
Follow-up survey: Study staff will contact participants at six months and administer an in-person follow-up survey; many of the questions administered at baseline will be assessed again.
Clinic records: Participants' health outcome data will be obtained from electronic clinic data via TIER.Net (South Africa's national electronic HIV/TB monitoring system), to assess individual- and facility-level outcomes related to HIV. Where necessary physical clinic files will be reviewed for confirmation. In addition, participants' data on laboratory tests relevant for HIV care (including viral load tests) will be requested from the National Health Laboratory Services (NHLS).
Coach Log Book: To collect data on the engagement between coaches and their clients, the coaches will maintain a log book of the dates, duration and mode (e.g., in-person, telephone call, WhatsApp messages) of contact with clients.
Randomization: Following the baseline survey, participants will be randomized (1:1) to a control group that receives the SOC and an intervention group that receives SOC plus the Coach Mpilo intervention.
Analyses: Primary analysis will be intention-to-treat using a logistic regression model that includes clinic fixed effects and month of enrollment, and controls for baseline participant characteristics that are significantly different between study groups. Similar analyses will be conducted for each secondary outcome.
Sample size and power calculations: With a sample size of 786 participants and 50% retention in care at 12 months, the study has 80% power to detect a difference of 10 percentage points between study groups. As a result, the study will aim to recruit about 800 participants in the Aim 1 trial.
Aim 2: Identify the populations of men who are not reached by and do not respond to Coach Mpilo In the intervention group, intervention uptake and amount of engagement participants have with a coach will be measured. Primary quantitative analysis will assess the determinants of uptake within the intervention group to advance the limited evidence on sub-groups that are typically missed by peer-led interventions and therefore require different types of support. Qualitative interviews will also be conducted to better understand program uptake and engagement with a coach.
Participants: Aim 2 will be conducted with data collected from coaches and from Aim 1 trial participants.
Follow-up procedures and data collection: In-depth interviews (IDIs) with participants in the intervention arm who decline a coach. The study will conduct about 15 IDIs with 1) men who decline the support of a coach to understand reasons they did not engage with a coach; 2) about 15 IDIs with men who, after initial engagement, decline the support of a coach, this will be in order to understand reasons they chose to end engagements with a coach; 3) about 15 IDIs with participants who receive support from a coach to understand engagement with coaches and elicit insights on reasons why the intervention may have worked for some participants but not others. IDIs will be conducted at about 6 months, when engagement with a coach will have ended.
IDIs with all coaches (about N=7) involved in the study will be conducted to gain insights on their engagement with participants.
Analyses: Primary quantitative analysis: Among Aim 1 intervention group participants analysis will evaluate factors associated with declining the offer of a coach using logistic regression, controlling for potential covariates. Qualitative data analysis: Data analysis will be iterative, and include both deductive and inductive approaches to thematic analysis.
Aim 3: Assess the cost-effectiveness of the Coach Mpilo program To inform strategic policy decisions about the scale-up of Coach Mpilo, and how it compares in cost and cost-effectiveness against current standard of care treatment, as well as other HIV interventions, we will conduct an economic evaluation. Data collection includes: cost-related data and resource utilization data to construct cost estimates for both arms. These data will be combined with retention in care data from Aim 1 to determine average costs per client retained in care and incremental cost per additional person retained. As part of the analysis, a sub-analysis will be conducted to adjust the cost estimates to reflect implementation in a routine care setting, excluding research-related expenses such as start-up and study-specific costs. This will provide more realistic national-level scale-up cost estimates for Coach Mpilo. Epidemiological modeling based on effectiveness estimates from Aim 1, will use the Thembisa model to estimate several long-term health outcomes, including life years saved and HIV infections averted due to onward transmission. These long-term health outcomes will form the basis to estimate the cost-effectiveness analysis of Coach Mpilo. To compare Coach Mpilo to other HIV prevention and treatment options in South Africa with the broader aim of informing strategic policy decisions, study estimates will be incorporated into the South Africa HIV Investment Case, a prominent initiative that assesses the relative cost-effectiveness of different HIV interventions and aims to inform government of the optimal mix of interventions that also accounts for allocative efficiency.
Analyses
The analyses will be conducted in three phases:
Cost analysis: a multiprong approach will be used that incorporates top-down and bottom-up costing methodologies to construct a cost for both standard of care and Coach Mpilo arms.
Cost-effectiveness analysis: both intermediate and long-term cost effectiveness analysis (using an HIV transmission model) will be conducted, comparing Coach Mpilo to standard of care.
Integration into the HIV Investment Case: the cost-effectiveness of Coach Mpilo to other HIV prevention and treatment options in South Africa will be compared to inform strategic policy decisions for the South African government.
Aim 4: Assess the acceptability, feasibility and fidelity of the Coach Mpilo program To inform intervention refinements and policy decisions on the scale-up of Coach Mpilo and peer-led interventions more generally, quantitative and qualitative assessment of implementation outcomes will be conducted alongside effectiveness and cost-effectiveness of the intervention. Implementation outcomes will be viewed as important for evaluation of complex health interventions in research and practice, providing indications into the implementation process as preconditions for attaining intended intervention engagement and health outcomes.
Sekhon's 2017 Theoretical Framework for Acceptability (TFA) will be used to assess the feasibility and acceptability of the intervention, informing interpretation of effectiveness overall (Aim 1), for sub-groups (Aim 2), and cost-effectiveness (Aim 3) by describing how acceptable the intervention is and how feasible the intervention is to deliver, from different stakeholder perspectives, and by describing the fidelity of the intervention.
The following data will be collected: i) primary quantitative survey data at baseline and six month follow-up (through Aim 1 survey instruments); ii) primary qualitative data from intervention arm participants that decline a coach, participants who are supported by a coach at six-month follow up, and coaches immediately after the intervention stops being implemented (through Aim 2 IDI instruments); iii) routine administrative data during intervention preparation and implementation.
Quantitative: At baseline, participants' affective attitude and values alignment will be assessed to understand prospective acceptability. In the follow up survey with intervention arm participants, the Acceptability of Intervention Measure (AIM)19, and the Client Satisfaction Questionnaire (CSQ-8) will be asked.
Qualitative: Follow-up in-depth-interviews described in Aim 2 include topics which answer our implementation research questions, focusing on retrospective acceptability
Coach log: an existing routine administrative data collection tool has been adapted to focus on implementation choices, their determinants, and coach-participant relationship quality.
Coach-to-Coach WhatsApp Group: the implementing partner routinely establishes a WhatsApp group used by Coaches and the Squad Manager (i.e. not including any clients/participants). Data from this group will include challenges Coaches are facing and solutions suggested by other coaches.
Monthly and quarterly implementation reports and follow-up discussions: these reports will be developed by Matchboxology, providing both quantitative data on reach and their own observations on fidelity, reach, mechanisms of change and implementation strategies and determinants.
Analysis: Quantitative analysis. Among Aim 1 intervention group participants, descriptive analysis of data from the AIM and CSQ-8 scales and linear regression analysis will be conducted to assess what factors at baseline were associated with these scales. Qualitative data analysis. Ongoing saturation analyses will be conducted, based on iterative coding during data collection. Data analysis will be iterative, and include both deductive and inductive approaches to thematic analysis.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Control group | No intervention | –Standard of care (SOC) in our study is a once-off telephonic contact by a Study Linkage Officer to encourage the participant to return to HIV care. The Linkage Officer is trained to conduct the call in line with the South African National Guidelines on tracing and recall which involved making telephonic contact with an individual who has missed their HIV clinic appointment by 7 days. The National Guidelines for tracing also include a potential home visit if the telephone call is unsuccessful. Given our study sample is limited to men who have missed HIV clinic appointments by more than 28 days, all participants should already have received the standard tracing services provided by the health facility. In the study we conduct the tracing telephone call again to make sure all participants have received this service. No other intervention is provided. |
| Coach Mpilo group | Experimental | Behavioral: Coach MpiloThe experimental group receives the standard of care for the control group (see control group description) and the Coach Mpilo intervention. Coach Mpilo employs 'coaches' (a term found to resonate with men and the concept of 'getting back in the game') to work 1-on-1 with men living with HIV ('players') and tailor support for each man to help him re-engage and stay in care. Coaches provide support for a period of up to six months, during which they engage with clients about once every week, with greater contact as needed based on the complexity of challenges faced. Coach Mpilo provides one-on-one, in-person support tailored to the individual needs of men living with HIV. As such, it may address the complex and varying psychosocial barriers to HIV care that traditional clinic-based interventions typically overlook. Coach Mpilo employs men living openly with HIV as coaches. This leverages the coaches' personal experiences to create a safe and supportive environment for clients. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Male (cisgender or transgender);
- aged ≥18 years;
- previously receiving HIV care at the study clinic;
- missed their most recent ART (antiretroviral therapy) clinic appointment by >28 days;
- not planning to relocate to another region within the next 12 months;
Key exclusion criteria (1 listed)
- not meeting inclusion criteria
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Coach MpiloThe experimental group receives the standard of care for the control group (see control group description) and the Coach Mpilo intervention. Coach Mpilo employs 'coaches' (a term found to resonate with men and the concept of 'getting back in the game') to work 1-on-1 with men living with HIV ('players') and tailor support for each man to help him re-engage and stay in care. Coaches provide support for a period of up to six months, during which they engage with clients about once every week, with greater contact as needed based on the complexity of challenges faced. Coach Mpilo provides one-on-one, in-person support tailored to the individual needs of men living with HIV. As such, it may address the complex and varying psychosocial barriers to HIV care that traditional clinic-based interventions typically overlook. Coach Mpilo employs men living openly with HIV as coaches. This leverages the coaches' personal experiences to create a safe and supportive environment for clients. | Behavioural | Coach Mpilo group |
Primary outcome
Retention in HIV care
Time frame: 12 months post study enrolment
Indicates whether a participant attended a follow-up clinic visit on or before 12 months after study enrolment and obtained adequate supply of antiretroviral therapy (ART) medication to have medication available at 12 months
14 secondary outcomes
ART clinic visit by 6 months
Time frame: 6 months post study enrolment
Retention in HIV care at 6 months
Time frame: 6 months post study enrolment
Viral load test completed at 6 months
Time frame: 6 months post study enrolment
Viral suppression at 6 months
Time frame: 3 to 9 months post study enrolment
Viral suppression at 12 months
Time frame: 9 to 15 months post study enrolment
HIV status disclosure to sexual partners
Time frame: 6 months post study enrolment
PHQ-9 scale
Time frame: 6 months post study enrolment
Mild to severe symptoms of mental depression
Time frame: 6 months post study enrolment
Moderate to severe symptoms of mental depression
Time frame: 6 months post study enrolment
GAD-7 scale
Time frame: 6 months post study enrolment
Mild to severe symptoms of anxiety
Time frame: 6 months post study enrolment
Moderate to severe symptoms of anxiety
Time frame: 6 months post study enrolment
Internalised stigma
Time frame: 6 months post study enrolment
Employment
Time frame: 6 months post study enrolment
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 May 2026.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: Yes. Survey data and in-depth interview data; excluding personal identifying information
Related trials for HIV
RecruitingObservational study
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
HIV, Substance Use Disorder
Not yet recruiting
Adapting the ESTEEM Intervention to Improve Mental Health and PrEP Uptake Among Men at Risk of HIV
PrEP Use
RecruitingPhase 2
Evaluating the Safety and Immunogenicity of MTBVAC
HIV I Infection, Tuberculosis
Active, not recruiting
Evaluating the Effectiveness of a Mobile HIV Prevention App to Increase HIV and Sexually Transmitted Infections (STI) Testing and PrEP Initiation Among Rural Men Who Have Sex With Men
HIV Infections, STI
Not yet recruiting
PNF RCT to Decrease Alcohol Use and Increase HIV Prevention
HIV (Human Immunodeficiency Virus), Alcohol Misuse
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Harsha Thirumurthy, PhD contact
Brendan G Maughan-Brown, PhD principal investigator
University of Cape Town
Harsha Thirumurthy, PhD principal investigator
University of Pennsylvania
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Coach Mpilo in people with HIV, run by University of Cape Town at 1 site in South Africa.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 11 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Africa. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Brendan G Maughan-Brown, PhD (+27216505696, brendan.maughan-brown@uct.ac.za), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Retention in HIV care (time frame: 12 months post study enrolment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2026.